<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2005-06-13" updated="2020-01-02">
  <drugbank-id primary="true">DB01718</drugbank-id>
  <drugbank-id>EXPT00048</drugbank-id>
  <drugbank-id>DB13159</drugbank-id>
  <name>Cetrimonium</name>
  <description>Cetrimonium is a quaternary ammonium cation whose salts are used as antiseptics.</description>
  <cas-number>6899-10-1</cas-number>
  <unii>Z7FF1XKL7A</unii>
  <average-mass>284.5435</average-mass>
  <monoisotopic-mass>284.331725349</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication/>
  <pharmacodynamics/>
  <mechanism-of-action/>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of organic compounds known as tetraalkylammonium salts. These are organonitrogen compounds containing a quaternary ammonium substituted with four alkyl chains.</description>
    <direct-parent>Tetraalkylammonium salts</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Organic nitrogen compounds</superclass>
    <class>Organonitrogen compounds</class>
    <subclass>Quaternary ammonium salts</subclass>
    <alternative-parent>Amines</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>Organic cations</alternative-parent>
    <alternative-parent>Organic salts</alternative-parent>
    <alternative-parent>Organopnictogen compounds</alternative-parent>
    <substituent>Aliphatic acyclic compound</substituent>
    <substituent>Amine</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>Organic cation</substituent>
    <substituent>Organic salt</substituent>
    <substituent>Organopnictogen compound</substituent>
    <substituent>Tetraalkylammonium salt</substituent>
  </classification>
  <salts>
    <salt>
      <drugbank-id primary="true">DBSALT001769</drugbank-id>
      <name>Cetrimonium bromide</name>
      <unii>L64N7M9BWR</unii>
      <cas-number>57-09-0</cas-number>
      <inchikey>LZZYPRNAOMGNLH-UHFFFAOYSA-M</inchikey>
      <average-mass>364.456</average-mass>
      <monoisotopic-mass>363.250063</monoisotopic-mass>
    </salt>
    <salt>
      <drugbank-id primary="true">DBSALT001772</drugbank-id>
      <name>Cetrimonium carboxydecyl PEG-8 dimethicone</name>
      <unii>0T3143V100</unii>
      <cas-number/>
      <inchikey/>
    </salt>
    <salt>
      <drugbank-id primary="true">DBSALT001770</drugbank-id>
      <name>Cetrimonium chloride</name>
      <unii>UC9PE95IBP</unii>
      <cas-number>112-02-7</cas-number>
      <inchikey>WOWHHFRSBJGXCM-UHFFFAOYSA-M</inchikey>
      <average-mass>320.0</average-mass>
      <monoisotopic-mass>319.3005781</monoisotopic-mass>
    </salt>
    <salt>
      <drugbank-id primary="true">DBSALT001771</drugbank-id>
      <name>Cetrimonium hydroxide</name>
      <unii>8Q7D6895LV</unii>
      <cas-number>505-86-2</cas-number>
      <inchikey>WJLUBOLDZCQZEV-UHFFFAOYSA-M</inchikey>
      <average-mass>301.559</average-mass>
      <monoisotopic-mass>301.334465009</monoisotopic-mass>
    </salt>
  </salts>
  <synonyms>
    <synonym language="english" coder="">Cetrimonium cation</synonym>
    <synonym language="english" coder="">Cetrimonium ion</synonym>
    <synonym language="english" coder="">Cetyl-Trimethyl-Ammonium</synonym>
    <synonym language="english" coder="">Cetyltrimethylammonium</synonym>
    <synonym language="english" coder="">Cetyltrimethylammonium cation</synonym>
    <synonym language="english" coder="">Cetyltrimethylammonium ion</synonym>
    <synonym language="english" coder="">Hexadecyltrimethylammonium</synonym>
    <synonym language="english" coder="">Hexadecyltrimethylammonium cation</synonym>
    <synonym language="english" coder="">Hexadecyltrimethylammonium ion</synonym>
    <synonym language="english" coder="">N,N,N-Trimethyl-1-hexadecanaminium</synonym>
    <synonym language="english" coder="">Trimethylhexadecylammonium</synonym>
  </synonyms>
  <products>
    <product>
      <name>Bye Bye Burn Lot</name>
      <labeller>David D. Daniels Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01978454</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-08-15</started-marketing-on>
      <ended-marketing-on>1998-01-15</ended-marketing-on>
      <dosage-form>Lotion</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Cetrimide Aqueous Soln 1%</name>
      <labeller>Ingram And Bell Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00120472</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1960-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-05</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Cetrimide Cream 0.5%</name>
      <labeller>Canadian Custom Packaging Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00874426</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1992-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Cetrimide Tincture 0.5%</name>
      <labeller>Canadian Custom Packaging Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00873195</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tincture</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Chlorhexidine-cetrimide Soltn Conc</name>
      <labeller>Bio Pharm, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00806269</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1989-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-09</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Resdan Dandruff Treatment Liquid 1%</name>
      <labeller>Wyeth Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01934007</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1992-12-31</started-marketing-on>
      <ended-marketing-on>2005-07-28</ended-marketing-on>
      <dosage-form>Liquid; Shampoo</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Salvesept Crm</name>
      <labeller>Protector Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01954091</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2012-06-18</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Savlodil</name>
      <labeller>Regent Medical Americas, Llc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02022206</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2012-07-31</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Savlon Crm 0.5%</name>
      <labeller>Whitehall Robins Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01932411</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2002-07-19</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Savlon Hospital Concentrate</name>
      <labeller>Durex Canada, Division Of Ssl Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02021005</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2005-07-14</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Xylonor</name>
      <labeller>Septodont</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02218607</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Spray, metered</dosage-form>
      <strength/>
      <route>Buccal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Xylonor Gel</name>
      <labeller>Septodont</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00479896</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Gel</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Xylonor Spray</name>
      <labeller>Septodont</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00319317</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1976-12-31</started-marketing-on>
      <ended-marketing-on>1998-04-16</ended-marketing-on>
      <dosage-form>Aerosol</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Xylonor</name>
      <ingredients>Cetrimonium + Lidocaine</ingredients>
    </mixture>
    <mixture>
      <name>Savlon Crm 0.5%</name>
      <ingredients>Cetrimonium</ingredients>
    </mixture>
    <mixture>
      <name>Savlon Hospital Concentrate</name>
      <ingredients>Cetrimonium + Chlorhexidine</ingredients>
    </mixture>
    <mixture>
      <name>Savlodil</name>
      <ingredients>Cetrimonium + Chlorhexidine</ingredients>
    </mixture>
    <mixture>
      <name>Salvesept Crm</name>
      <ingredients>Cetrimonium + Chlorhexidine</ingredients>
    </mixture>
    <mixture>
      <name>Cetrimide Aqueous Soln 1%</name>
      <ingredients>Cetrimonium</ingredients>
    </mixture>
    <mixture>
      <name>Bye Bye Burn Lot</name>
      <ingredients>Allantoin + Benzocaine + Cetrimonium + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Xylonor Spray</name>
      <ingredients>Cetrimonium + Lidocaine</ingredients>
    </mixture>
    <mixture>
      <name>Resdan Dandruff Treatment Liquid 1%</name>
      <ingredients>Cetrimonium</ingredients>
    </mixture>
    <mixture>
      <name>Chlorhexidine-cetrimide Soltn Conc</name>
      <ingredients>Cetrimonium + Chlorhexidine</ingredients>
    </mixture>
    <mixture>
      <name>Cetrimide Cream 0.5%</name>
      <ingredients>Cetrimonium</ingredients>
    </mixture>
    <mixture>
      <name>Xylonor Gel</name>
      <ingredients>Cetrimonium + Lidocaine</ingredients>
    </mixture>
    <mixture>
      <name>Cetrimide Tincture 0.5%</name>
      <ingredients>Cetrimonium</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Amines</category>
      <mesh-id>D000588</mesh-id>
    </category>
    <category>
      <category>Ammonium Compounds</category>
      <mesh-id>D064751</mesh-id>
    </category>
    <category>
      <category>Anti-Infective Agents</category>
      <mesh-id>D000890</mesh-id>
    </category>
    <category>
      <category>Anti-Infective Agents, Local</category>
      <mesh-id>D000891</mesh-id>
    </category>
    <category>
      <category>Antiseptics and Disinfectants</category>
      <mesh-id/>
    </category>
    <category>
      <category>Cetrimonium Compounds</category>
      <mesh-id>D002593</mesh-id>
    </category>
    <category>
      <category>Compounds used in a research, industrial, or household setting</category>
      <mesh-id>D020313</mesh-id>
    </category>
    <category>
      <category>Dermatologicals</category>
      <mesh-id>D003879</mesh-id>
    </category>
    <category>
      <category>Medicated Shampoos</category>
      <mesh-id/>
    </category>
    <category>
      <category>Miscellaneous Local Anti-infectives</category>
      <mesh-id/>
    </category>
    <category>
      <category>Nitrogen Compounds</category>
      <mesh-id>D017672</mesh-id>
    </category>
    <category>
      <category>Onium Compounds</category>
      <mesh-id>D009861</mesh-id>
    </category>
    <category>
      <category>Quaternary Ammonium Compounds</category>
      <mesh-id>D000644</mesh-id>
    </category>
    <category>
      <category>Throat Preparations</category>
      <mesh-id/>
    </category>
    <category>
      <category>Trimethyl Ammonium Compounds</category>
      <mesh-id>D050337</mesh-id>
    </category>
  </categories>
  <affected-organisms/>
  <dosages>
    <dosage>
      <form>Lotion</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Tincture</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid; shampoo</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Cream</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Cream</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Spray, metered</form>
      <route>Buccal</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Gel</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Aerosol</form>
      <route>Topical</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes>
    <atc-code code="D08AJ04">
      <level code="D08AJ">Quaternary ammonium compounds</level>
      <level code="D08A">ANTISEPTICS AND DISINFECTANTS</level>
      <level code="D08">ANTISEPTICS AND DISINFECTANTS</level>
      <level code="D">DERMATOLOGICALS</level>
    </atc-code>
    <atc-code code="D11AC01">
      <level code="D11AC">Medicated shampoos</level>
      <level code="D11A">OTHER DERMATOLOGICAL PREPARATIONS</level>
      <level code="D11">OTHER DERMATOLOGICAL PREPARATIONS</level>
      <level code="D">DERMATOLOGICALS</level>
    </atc-code>
    <atc-code code="R02AA17">
      <level code="R02AA">Antiseptics</level>
      <level code="R02A">THROAT PREPARATIONS</level>
      <level code="R02">THROAT PREPARATIONS</level>
      <level code="R">RESPIRATORY SYSTEM</level>
    </atc-code>
    <atc-code code="D08AJ02">
      <level code="D08AJ">Quaternary ammonium compounds</level>
      <level code="D08A">ANTISEPTICS AND DISINFECTANTS</level>
      <level code="D08">ANTISEPTICS AND DISINFECTANTS</level>
      <level code="D">DERMATOLOGICALS</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes>
    <ahfs-code>84:04.92</ahfs-code>
  </ahfs-codes>
  <pdb-entries>
    <pdb-entry>1kpg</pdb-entry>
    <pdb-entry>1tpy</pdb-entry>
    <pdb-entry>3b00</pdb-entry>
    <pdb-entry>3hf0</pdb-entry>
    <pdb-entry>3p73</pdb-entry>
    <pdb-entry>5hxw</pdb-entry>
  </pdb-entries>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>2.48</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-7.8</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>5.24e-06 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>2.69</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>hexadecyltrimethylazanium</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>cetyl-trimethyl-ammonium</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>284.5435</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>284.331725349</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>CCCCCCCCCCCCCCCC[N+](C)(C)C</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C19H42N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C19H42N/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(2,3)4/h5-19H2,1-4H3/q+1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>RLGQACBPNDBWTB-UHFFFAOYSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>104.99</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>41.09</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>15</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Water Solubility</kind>
      <value>1E+005 mg/L</value>
      <source>MERCK INDEX (1996)</source>
    </property>
    <property>
      <kind>Melting Point</kind>
      <value>240 Â°C</value>
      <source>PhysProp</source>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>7145</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>2199</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>39561</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>2681</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46507665</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Compound</resource>
      <identifier>C11275</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Drug</resource>
      <identifier>D03454</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>2580</identifier>
    </external-identifier>
    <external-identifier>
      <resource>BindingDB</resource>
      <identifier>58941</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PDB</resource>
      <identifier>16A</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Cetrimonium</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL1183605</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target>
      <id>BE0002512</id>
      <name>Cyclopropane mycolic acid synthase MmaA2</name>
      <organism>Mycobacterium tuberculosis</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1991</ref-id>
            <pubmed-id>10592235</pubmed-id>
            <citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q79FX6" source="Swiss-Prot">
        <name>Cyclopropane mycolic acid synthase MmaA2</name>
        <general-function>Methyltransferase activity</general-function>
        <specific-function>Catalyzes the conversion of a double bond to a cis cyclopropane ring at the distal position of an alpha mycolic acid via the transfer of a methylene group from S-adenosyl-L-methionine. MmaA2 also catalyzes the biosynthesis of the cis-cyclopropanated methoxymycolates. Cyclopropanated mycolic acids are key factors participating in cell envelope permeability, host immunomodulation and persistence.</specific-function>
        <gene-name>mmaA2</gene-name>
        <locus/>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>5.73</theoretical-pi>
        <molecular-weight>32724.06</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="83332">Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>BX842574</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q79FX6</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>MMAA2_MYCTU</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.1.1.79</synonym>
          <synonym>AdoMet-MT</synonym>
          <synonym>CFA synthase</synonym>
          <synonym>CMAS</synonym>
          <synonym>Cyclopropane-fatty-acyl-phospholipid synthase</synonym>
          <synonym>MA-MT</synonym>
          <synonym>mma2</synonym>
          <synonym>Mycolic acid methyltransferase</synonym>
          <synonym>S-adenosylmethionine-dependent methyltransferase</synonym>
          <synonym>SAM-MT</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011791|Cyclopropane mycolic acid synthase MmaA2
MVNDLTPHFEDVQAHYDLSDDFFRLFLDPTQTYSCAHFEREDMTLEEAQIAKIDLALGKL
GLQPGMTLLDIGCGWGATMRRAIAQYDVNVVGLTLSKNQAAHVQKSFDEMDTPRDRRVLL
AGWEQFNEPVDRIVSIGAFEHFGHDRHADFFARAHKILPPDGVLLLHTITGLTRQQMVDH
GLPLTLWLARFLKFIATEIFPGGQPPTIEMVEEQSAKTGFTLTRRQSLQPHYARTLDLWA
EALQEHKSEAIAIQSEEVYERYMKYLTGCAKLFRVGYIDVNQFTLAK</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0011792|Cyclopropane mycolic acid synthase MmaA2 (mmaA2)
ATGGTCAACGACCTAACGCCGCACTTCGAGGACGTGCAGGCACACTACGACCTGTCCGAC
GACTTCTTCCGGCTGTTCCTGGATCCGACCCAGACCTACAGCTGCGCGCATTTCGAACGC
GAGGACATGACGCTGGAAGAGGCCCAGATCGCCAAGATCGACCTGGCGCTGGGCAAGCTA
GGTCTGCAGCCCGGCATGACGCTGCTCGATATCGGTTGCGGCTGGGGCGCCACCATGCGG
CGCGCGATCGCGCAGTATGACGTCAACGTCGTCGGCCTGACATTGTCGAAGAACCAGGCC
GCCCATGTGCAGAAGTCGTTCGACGAGATGGACACCCCGCGCGACAGGCGAGTGTTGCTG
GCGGGATGGGAGCAGTTCAACGAGCCCGTCGACCGCATCGTGTCGATCGGCGCGTTCGAG
CACTTCGGCCACGATCGTCACGCCGACTTCTTCGCCCGGGCCCACAAAATCCTGCCGCCC
GATGGCGTGTTGCTGCTGCACACGATCACCGGCCTGACCAGGCAGCAGATGGTCGACCAC
GGCTTGCCGCTCACGTTGTGGCTGGCCCGCTTTCTCAAGTTCATCGCGACCGAAATCTTC
CCGGGGGGCCAACCTCCGACGATTGAAATGGTTGAGGAACAGTCGGCGAAGACGGGTTTC
ACGCTGACTCGCCGCCAGTCGCTGCAGCCGCATTACGCCAGGACCCTCGACCTGTGGGCC
GAGGCGCTGCAGGAACACAAAAGCGAGGCCATCGCGATCCAGTCCGAAGAGGTCTACGAG
CGGTACATGAAATACCTGACCGGCTGCGCCAAGCTGTTCCGGGTCGGCTACATCGACGTC
AACCAGTTCACGCTGGCGAAGTAG</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF02353</identifier>
            <name>CMAS</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cell wall</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>cyclopropane-fatty-acyl-phospholipid synthase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>methyltransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>mycolic acid biosynthetic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="1">
      <id>BE0003738</id>
      <name>Cyclopropane mycolic acid synthase 1</name>
      <organism>Mycobacterium tuberculosis</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1991</ref-id>
            <pubmed-id>10592235</pubmed-id>
            <citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P9WPB7" source="Swiss-Prot">
        <name>Cyclopropane mycolic acid synthase 1</name>
        <general-function>Catalyzes the conversion of a double bond to a cyclopropane ring at the distal position of an alpha mycolic acid via the transfer of a methylene group from S-adenosyl-L-methionine. Cyclopropanated mycolic acids are key factors participating in cell envelope permeability, host immunomodulation and persistence.</general-function>
        <specific-function>Cyclopropane-fatty-acyl-phospholipid synthase activity</specific-function>
        <gene-name>cmaA1</gene-name>
        <locus/>
        <cellular-location>Cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi/>
        <molecular-weight>32460.98</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="83332">Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P9WPB7</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>CMAS1_MYCTU</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.1.1.79</synonym>
          <synonym>AdoMet-MT</synonym>
          <synonym>CFA synthase</synonym>
          <synonym>cma1</synonym>
          <synonym>CMAS</synonym>
          <synonym>CMAS-1</synonym>
          <synonym>Cyclopropane fatty acid synthase</synonym>
          <synonym>Cyclopropane-fatty-acyl-phospholipid synthase</synonym>
          <synonym>MA-MT</synonym>
          <synonym>Mycolic acid methyltransferase</synonym>
          <synonym>S-adenosylmethionine-dependent methyltransferase</synonym>
          <synonym>SAM-MT</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0051219|Cyclopropane mycolic acid synthase 1
MPDELKPHFANVQAHYDLSDDFFRLFLDPTQTYSCAYFERDDMTLQEAQIAKIDLALGKL
GLQPGMTLLDVGCGWGATMMRAVEKYDVNVVGLTLSKNQANHVQQLVANSENLRSKRVLL
AGWEQFDEPVDRIVSIGAFEHFGHERYDAFFSLAHRLLPADGVMLLHTITGLHPKEIHER
GLPMSFTFARFLKFIVTEIFPGGRLPSIPMVQECASANGFTVTRVQSLQPHYAKTLDLWS
AALQANKGQAIALQSEEVYERYMKYLTGCAEMFRIGYIDVNQFTCQK</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0051220|Cyclopropane mycolic acid synthase 1 (cmaA1)
ATGCCCGACGAGCTGAAGCCGCACTTCGCCAACGTGCAGGCGCACTACGACCTGTCCGAC
GACTTCTTCCGGCTGTTCCTCGATCCCACTCAGACCTACAGCTGCGCCTACTTCGAGCGC
GACGACATGACGCTGCAAGAGGCGCAGATCGCCAAGATCGATCTCGCGCTGGGCAAACTC
GGATTGCAGCCGGGCATGACACTGTTGGACGTCGGCTGCGGCTGGGGCGCCACCATGATG
CGCGCGGTGGAAAAATACGACGTCAACGTCGTCGGTCTGACCCTGAGCAAAAACCAGGCC
AACCACGTTCAGCAGCTGGTCGCCAACTCCGAAAATCTACGCTCCAAACGCGTTCTGCTG
GCCGGCTGGGAACAGTTTGACGAGCCCGTCGACCGCATCGTCAGCATCGGTGCTTTCGAA
CATTTCGGTCACGAGCGCTACGACGCGTTCTTCAGCCTGGCGCATCGCCTGCTGCCCGCT
GACGGGGTCATGCTGCTGCACACCATCACCGGGTTGCATCCGAAAGAGATCCACGAACGC
GGCCTGCCCATGTCGTTCACCTTCGCTCGTTTCCTGAAATTCATTGTGACCGAGATCTTT
CCGGGTGGGCGGCTGCCCTCGATACCGATGGTGCAGGAGTGTGCCAGCGCAAACGGCTTC
ACCGTCACCAGAGTTCAATCGTTGCAGCCGCACTATGCGAAAACCCTCGACCTCTGGTCC
GCGGCGTTGCAGGCCAACAAGGGCCAGGCCATCGCGCTGCAATCCGAGGAAGTCTACGAG
CGGTATATGAAGTACCTCACCGGCTGCGCCGAGATGTTTCGCATCGGATACATCGACGTC
AACCAGTTCACCTGCCAGAAGTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF02353</identifier>
            <name>CMAS</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>cyclopropane-fatty-acyl-phospholipid synthase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>lipid biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>mycolic acid biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>S-adenosylmethionine metabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>